Chemokine N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 1,25 MB, PDF-dokument

Inflammatory chemokines are often elevated in disease settings, where the largest group of CC-chemokines are the macrophage inflammatory proteins (MIP), which are promiscuous for the receptors CCR1 and CCR5. MIP chemokines, such as CCL3 and CCL5 are processed at the N terminus, which influences signaling in a highly diverse manner. Here, we investigate the signaling capacity of peptides corresponding to truncated N termini. These 3–10-residue peptides displayed weak potency but, surprisingly, retained their signaling on CCR1. In contrast, none of the peptides generated a signal on CCR5, but a CCL3-derived tetrapeptide was a positive modulator boosting the signal of several chemokine variants on CCR5. In conclusion, chemokine N termini can be mimicked to produce small CCR1-selective agonists, as well as CCR5-selective modulators.

OriginalsprogEngelsk
TidsskriftFEBS Letters
Vol/bind597
Udgave nummer24
Sider (fra-til)3049-3060
ISSN0014-5793
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
This study was supported by the European Research Council: VIREX (grant agreement 682549, call ERC‐2105‐CoG), the Lundbeck Foundation (R268‐2017‐409) and a C1 grant from KU Leuven (C16/17/010). SS is supported by a PhD fellowship from FWO‐Vlaanderen (1116922 N).

Publisher Copyright:
© 2023 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

ID: 377451683